Our study demonstrates that about nine percent of medullary like breast cancer patients without any known positive family history were BRCA1 gene mutation carriers, whereas no pathogenic somatic BRCA1/2 mutations could be found. This evidence concerns the gene BRCA1 and breast cancer.